You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
North American Clinical Chemistry The North American clinical chemistry market was estimated at $3,852.7 million in 2013 and is expected to reach $5,370.5 million by 2019, at a CAGR of 7.2% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Global Spirometers Market The “Global Spirometer Market”, mainly driven by increase of respiratory diseases, was pegged at $ 397 million in 2012 and expected to be $ 661 billion by 2020, growing at a CAGR of 6.5%. The market has 2 segments such as Table-top and Handheld monitors. The major player in the market are CareFusion (U.S.), Cosmed (Italy), Philips Healthcare (Netherlands), Micro Direct (U.K.), Schiller (Switzerland), Welch Allyn (U.S.), and SDI Diagnostics (U.S.). |
Upcoming |
|
|
Oxygen Delivery Systems The global oxygen delivery systems market forms an integral part of the healthcare industry. The market was valued at $548 million in 2013 and is expected to reach a value of $1.6 billion in 2018, at a CAGR of 16.2% from 2013 to 2018. The market has been segmented on the basis of products, geographies, end users, companies, and macro indicators. A deep-dive analysis of the key players in the market has been provided in this report. |
Upcoming |
|
|
North American Cardiac Monitoring Devices North America is the world leader for the Cardiac Monitoring Devices Market.The Cardiac Monitoring Devices Market can be segmented on the basis of devices, geography, Companies and Macroindicator.Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
European Cardiac Monitoring Devices Europe has the second largest share in the Global Cardiac Monitoring Devices Market.The Cardiac Monitoring Devices Market can be segmented on the basis of devices, geography, Companies and Macroindicator.Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Asian Cardiac Monitoring Devices Market Volume growth is significantly higher in Asia (India, China, Japan) because of rising incidence of CVD and increased purchasing power of patients in India and China will drive this market.The Cardiac Monitoring Devices Market can be segmented on the basis of devices, geography, Companies and Macroindicator.Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Positive Airway Pressure (PAP) The global Positive Airway Pressure (PAP) device market has gained tremendous importance owing to the large patient base of Obstructive Sleep Apnea (OSA). The market was valued at $4.7 billion in 2013 and is expected to reach a value of $10.4 billion in 2018, with a CAGR of 17.3% from 2013 to 2018. The market has been segmented on the basis of products, geographies, end users, companies, and macro indicators. A deep-dive analysis of the key players has been provided in this report. |
Upcoming |
|
|
Anesthesia Monitoring Devices The “Global Anesthesia monitoring devices Market”, mainly driven by increase in the number of surgeries, was pegged at $ 414 million in 2012 and expected to be $ 618 million by 2020, growing at a CAGR of 6.8%. The report analyzes the market of monitors by 2 segments such as Portable and Stationary. The main companies operating in the market and extensively covered in this report are GE Healthcare, Philips, Mindray, Covidien, Drager, etc. |
Upcoming |
|
|
Facial Interfaces The Global Facial Interface market constitutes a growing market and a prime part of the Healthcare industry. Masks forms the major contributor in this market and is growing at a CAGR of 17.2% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
|
|
Americas Electrical Ablation The American Electrical Ablation Market was pegged at $387 million in 2013 and expected to be $480 million by 2018,. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in electrical ablation market are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland). |
Upcoming |
|
|
Asia-Pacific Electrical Ablation The Asia-Pacific electrical ablation market was valued at $159.0 million in 2013 and is expected to reach $236.0 million by 2018. In the electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in Asia-Pacific Electrical Ablation market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
European Electrical Ablation The European electrical ablation market was valued at $189.0 million in 2013 and is expected to reach $228.0 million by 2018. In the European electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
Americas Hydrothermal Ablation The American Hydrothermal Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in hydrothermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others |
Upcoming |
|
|
Asia-Pacific Hydrothermal Ablation The Asia-Pacific Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The main companies operating in Hydrothermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
European Hydrothermal Ablation The European Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The main companies operating in Hydrothermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
North American Cardiac Rhythm Management Devices The North American Cardiac Rhythm Management Devices Market, mainly driven by Increasing Incidence of Lifestyle Diseases &Cardiovascular Diseases, was pegged at $ 4.25 billion in 2012 and expected to be $ 8.04 billion by 2018.The market is segmented by Type of devices, Geography, Companies and Macroindicator. Deep dive analysis of the major players of this market are considered in this report. |
Upcoming |
|
|
Americas Light/Laser Ablation The American Light/Laser Ablation Market, was pegged at $347 million in 2013 and expected to be $527 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others. |
Upcoming |
|
|
Asia-Pacific Light/Laser Ablation The Asia-Pacific Light/Laser Ablation Market was pegged at $192 million in 2013 and expected to be $330 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others. |
Upcoming |
|
|
European Light/Laser Ablation The European Light/Laser Ablation Market was pegged at $298 million in 2013 and expected to be $450 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others. |
Upcoming |
|
|
Americas Microwave Ablation The American Microwave Ablation Market was pegged at $75 million in 2013 and expected to be $133 million by 2018. Currently there are very few players in microwave ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S). |
Upcoming |
Healthcare
